AJR InPractice
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Recaldini, C.
Right arrow Articles by Fugazzola, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Recaldini, C.
Right arrow Articles by Fugazzola, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.07.2184
AJR 2007; 189:1303-1306
© American Roentgen Ray Society


Original Research

Percutaneous Sonographically Guided Radiofrequency Ablation of Medium-Sized Fibroids: Feasibility Study

Chiara Recaldini1, Gianpaolo Carrafiello1, Domenico Laganà1, Salvatore Cuffari2, Valentino Bergamini3, Fabio Ghezzi4 and Carlo Fugazzola1

1 Department of Radiology, University of Insubria, Viale Borri 57, 21100 Varese, Italy.
2 Service of Anesthesiology, University of Insubria, Varese, Italy.
3 Department of Obstetrics and Gynecology, University of Verona, Verona, Italy.
4 Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy.

OBJECTIVE. The purpose of this study was to assess the feasibility and safety of percutaneous radiofrequency ablation under sonographic guidance as a unique procedure in the management of symptomatic uterine myomas.

SUBJECTS AND METHODS. Six premenopausal women with symptomatic submucosal or intramural uterine myomas underwent percutaneous radiofrequency ablation under suprapubic sonographic guidance. Relief of symptoms and reduction in the diameter and volume of the myomas were measured every 3 months.

RESULTS. The location of myomas was anterior and submucosal in one of the six patients and intramural in the other five (one posterior, one anterior, two fundal, and one on the left side). Five of the patients had pelvic pain, and four had menorrhagia. The median baseline diameter was 4.8 cm (range, 4.4–5.2 cm), and the mean volume was 58.57 cm3 (range, 44.58–73.58 cm3). The mean follow-up time was 9 months (range, 3–12 months). At follow-up, the median diameter was 2.3 cm (range, 1.20–3.2 cm), and the median volume was 8.97 cm3 (range, 0.90–18.81 cm3). The median preoperative symptom score was 47.2 (31.8–67.30), and the median health-related quality of life (QOL) score was 63.92 (37.20–86.00). The median symptom score during follow-up was 5.15 (range, 0–26), and the mean QOL score was 96.2 (range, 86.30–100). Four of six patients were symptom-free at the last follow-up visit.

CONCLUSION. Percutaneous sonographically guided radiofrequency ablation alone is a feasible and efficient procedure in the management of medium-sized uterine myomas.

Keywords: radiofrequency thermal ablation • sonography • uterine myoma


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.